Workshop on Biorelevant in vitro Performance Testing

Workshop on Biorelevant in vitro Performance Testing of Orally Administered Dosage Forms. Jointly organised by FIP and DIA

Medical & Health Care

Workshop on Biorelevant in vitro Performance Testing 24-25 Sep 2014 NH Musica, Amsterdam, Netherlands
Submit new post
Thank you for posting.
Share it:

OverviewBiorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behaviour.

Biorelevant dissolution/release testing is useful for the evaluation of formulation and food effects on plasma levels and intraluminal dosage form performance after administration of oral drug products.

It has also been utilised to decrease the number of in vivo studies required during the drug development process and to mitigate the risk related to in vivo bioequivalence studies.

This workshop will discuss data on the luminal environment, its simulation, biorelevant in vitro performance testing methodologies that can be applied during product development, as well as relevant in silico modelling methodologies.

Case studies from industry will describe the application of biorelevant testing methodologies for formulation design, selection and development vs. currently applied procedures in quality control testing.

In addition, presentations from the FDA and National Competent Authorities will cover the use of biorelevant testing in the evaluation of a drug’s performance.

Member Standard: 1420

From: September 24, 2014 13:00
To: September 25, 2014 17:00

NH Musica, 221 Van Leijenberghlaan, 1082 GG, Amsterdam, Netherlands


Medical & Health Care

Contact email

Contact phone
+41 61 225 5151


Submitted by:

evvnt Platform

Are you the organizer?

Get in touch